GlassScriptPhysician profile
Paul J Lynch
NPI 1013061076
$282,563.33
in general payments reported to CMS, 2019-2025
26 companies · $1,815 in 2025
The $1,815 reported for 2025 was more than what 76% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,418 · 2020: $27K · 2021: $98K · 2022: $107K · 2023: $31K · 2024: $16K · 2025: $1,815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,140 · Food and Beverage: $4,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,890.00 |
| Travel and Lodging | $10,794.62 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,140.00 |
| Food and Beverage | $4,779.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $157,699.19 | 2019-2024 | Senza, Omnia |
| Nalu Medical, INC. | $92,192.37 | 2021-2025 | Nalu Neurostimulation System |
| Omnia Medical, LLC | $15,079.96 | 2021-2022 | |
| Boston Scientific Corporation | $9,999.63 | 2020-2024 | |
| Abbott Laboratories | $2,876.79 | 2019-2025 | Eterna, Proclaim, Prodigy |
| Vertos Medical, INC. | $1,266.98 | 2019-2024 | Mild Device Kit |
| Medtronic, INC. | $941.98 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Foundation Fusion Solutions, LLC | $378.82 | 2021-2025 | |
| Si-Bone, INC. | $351.63 | 2024-2025 | |
| Curonix LLC | $334.54 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Axonics, INC. | $333.79 | 2021-2024 | Axonics |
| Stimwave Technologies Incorporated | $297.42 | 2019-2022 | |
| Mml US, INC. | $135.25 | 2022 | |
| Nuvasive, INC. | $122.27 | 2021 | |
| Saluda Medical Americas, INC. | $105.58 | 2025 | Evoke |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $94.13 | 2019-2025 | Sprint Pns System |
| Watermark Medical, INC. | $65.62 | 2021 | |
| Relievant Medsystems, INC. | $58.94 | 2019 | |
| Globus Medical, INC. | $56.78 | 2025 | Vyrsa V1 |
| Biodelivery Sciences International, INC. | $44.88 | 2020-2021 | |
| Painteq LLC | $37.80 | 2021-2024 | Painteq |
| Depuy Synthes Sales INC. | $27.11 | 2025 | Orthovisc |
| Abbvie INC. | $19.97 | 2022 | |
| Allergan, INC. | $15.83 | 2019 | |
| Scilex Pharmaceuticals INC. | $14.82 | 2019 | |
| Integra Lifesciences Corporation | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.